This first week of April is Adolescent and Young Adult (AYA) Cancer Awareness Week, an opportunity to shine a light on the unique challenges that teen and young adult cancer patients and survivors face. According to the National Cancer Institute, about 89,000 young people (ages 15 to 39) are diagnosed with cancer each year in the United States—accounting for about five percent of cancer diagnoses in the United States. Medulloblastoma survivor Victoria shared with us the impact of being diagnosed with a brain tumor that had also spread into her spine as a young adult. “Going through so ..read more

  We've got the perfect way for you to show kids with cancer some love this Valentine's Day: Join us in a day of action!   Thanks to advocates like you, we've been able to make great strides in the fight against childhood cancer. One way that we achieve progress is by working closely with our partners in the Alliance for Childhood Cancer, a coalition of which Children’s Cancer Cause is a founding member. We're on Capitol Hill this week for the 14th Annual Alliance for Childhood Cancer Action Days, joining with advocates from all around the country in meetings with lawmakers and ..read more

  Pictured: City of Hope’s Childhood, Adolescent and Young Adult (AYA) Cancer Survivorship Program team We’re pleased to share this impact update from our 2023 Survivorship Champion’s Prize recipient: City of Hope’s Long Term Follow-Up Clinic for Survivors of Childhood, Adolescent and Young Adult (AYA) Cancer. The $10,000 Champion’s Prize is awarded annually to a group, program, or institution making significant advances in programs and services to provide lifelong health maintenance for survivors of childhood cancers. Read on to learn about how funds from the Champion’s Prize are making ..read more

  To keep families and advocates well-informed of new developments in pediatric oncology and survivorship research, we’re bringing you a round-up of some of the studies and articles we’ve been digesting lately. 2024 Cancer Outlook: The American Cancer Society released its 2024 Cancer Facts & Figures report this month, and their numbers estimate that approximately 9,620 children ages 0-14 and 5,290 adolescents (15-19) will be diagnosed with cancer in 2024. Incidence rates in children have stabilized since 2015 but continue to increase for adolescents by about 1 percent per year. The m ..read more

  Thanks to you - childhood cancer families, friends, advocates, and supporters - we’ve been able to achieve so much in 2023. As the year comes to a close, we’re taking a look back at some of the most notable moments for the childhood cancer community and for Children’s Cancer Cause. 2023 was a big year for legislative achievements. To kick things off, President Biden signed the Childhood Cancer STAR Reauthorization Act into law just days into the new year. This was a major legislative victory that will impact the future of pediatric cancer research and the delivery of care for the rest ..read more

  We're proud to announce that a bipartisan bill was introduced in the House last week to strengthen the development of childhood cancer drugs. For the past several years, Children’s Cancer Cause has advocated that the FDA have the same authority to penalize companies who fail to complete required studies for pediatric drugs as they currently have for studies of adult drugs. The Innovation in Pediatric Drugs Act of 2023 (H.R. 6664) strives to achieve that equity. We thank Rep. Anna Eshoo (D-Calif.) and Rep. Mike McCaul (R-Texas) for their leadership as sponsors of this bill. Here's what ..read more

This first week of December is #CancerScreenWeek, a time for all of us to take stock and make sure we're up-to-date on cancer screenings like those for breast, skin, and colon health. For childhood cancer survivors, this is especially critical. First, let’s talk about relapse. The odds of a survivor relapsing varies widely depending on the type and severity of the cancer and the type of treatment received. This is why it’s so important to have a treatment summary and Survivorship Care Plan — so survivors understand their unique risk factors and recommended health screenings. Sometimes a relap ..read more

  On behalf of the Stewart Initiative for Childhood Cancer Survivors, Children’s Cancer Cause is pleased to bring you a final update on how funding from the 2022 Survivorship Champion’s Prize is being used to advance survivorship care. Each of the four programs that received funding in 2022 shared with us how the awards made a difference in their survivorship services over the past year. The Phoenix Children’s Hospital Survivorship Program received our top Survivorship Champion’s Prize award in 2022. “I am happy to report that the funds have made a significant positive impact on our sur ..read more

    In recognition of their extraordinary leadership in combatting childhood cancer, Steven Joffe, MD, MPH, and Vickie Buenger, PhD, received special awards from Children’s Cancer Cause at our signature event of the year in New York City. These awards recognize leading advocates helping to achieve progress for the 16,000 children diagnosed with cancer each year in the United States and the 500,000 survivors of childhood cancer around the country. Dr. Joffe, a pediatric oncologist with specialty in the ethical complexities of pediatric oncology research, is the recipient of the 2023 ..read more

  We’re so proud to name the Childhood, Adolescent and Young Adult (AYA) Cancer Survivorship Program at City of Hope, one of the largest cancer research and treatment organizations in the United States, as the recipient of the 2023 Survivorship Champion’s Prize. The $10,000 Champion’s Prize is awarded annually to a group, program, or institution making significant advances in programs and services to provide lifelong health maintenance for survivors of childhood cancers. The City of Hope Childhood, Adolescent and Young Adult Cancer Survivorship Program was selected based on their multidi ..read more